ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,760,000 | +43.3% | 600,000 | 0.0% | 1.82% | +44.8% |
| Q4 2017 | $1,926,000 | -44.7% | 600,000 | -46.9% | 1.25% | +30.6% |
| Q3 2017 | $3,480,000 | +527.0% | 1,130,000 | +653.3% | 0.96% | +205.7% |
| Q2 2017 | $555,000 | +13.7% | 150,000 | +50.0% | 0.31% | +30.3% |
| Q1 2017 | $488,000 | -4.7% | 100,000 | 0.0% | 0.24% | -21.2% |
| Q4 2016 | $512,000 | -76.4% | 100,000 | -66.7% | 0.31% | -20.9% |
| Q3 2016 | $2,172,000 | +191.9% | 300,000 | +140.0% | 0.39% | +27.7% |
| Q2 2016 | $744,000 | – | 125,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,608,171 | $8,624,000 | 2.44% |
| Broadfin Capital, LLC | 4,226,077 | $10,100,000 | 1.33% |
| MORGENS WATERFALL VINTIADIS & CO INC | 400,000 | $956,000 | 0.85% |
| Consonance Capital Management LP | 4,588,352 | $10,966,000 | 0.81% |
| Perceptive Advisors | 6,521,102 | $14,542,000 | 0.55% |
| Diag Capital Management, LP | 182,100 | $435,000 | 0.50% |
| 683 Capital Management, LLC | 805,000 | $1,924,000 | 0.12% |
| ARDSLEY ADVISORY PARTNERS LP | 50,000 | $120,000 | 0.03% |
| AVANTAX ADVISORY SERVICES, INC. | 65,050 | $156,000 | 0.03% |
| PURA VIDA INVESTMENTS, LLC | 37,170 | $89,000 | 0.02% |